Overview

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of buprenorphine on QT interval corrected for heart rate (QTc) in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Purdue Pharma LP
Treatments:
Buprenorphine
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination